BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22130234)

  • 1. Activation of vasculogenic progenitor cells by ent-16α,17-dihydroxy-kauran-19-oic acid.
    Park SH; Jeong YM; Kim JH; Chung HM; Suh W; Sung SH; Park SG; Sung JH
    Biol Pharm Bull; 2011; 34(12):1801-7. PubMed ID: 22130234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal regeneration by ent-16α, 17-dihydroxy-kauran-19-oic acid isolated from Siegesbeckia pubescens.
    Sung SH; Park SH; Song SY; Lee SJ; Lee HW; Kim SH; A Lee M; Yoon IS; Kim DD; Kang S; Sung JH
    Cell Prolif; 2011 Dec; 44(6):527-36. PubMed ID: 21992237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
    Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
    Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase.
    Jeong W; Song G; Bazer FW; Kim J
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):175-84. PubMed ID: 24508636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 27 phosphorylation in the proliferation and apoptosis of human umbilical vein endothelial cells induced by high glucose through the phosphoinositide 3‑kinase/Akt and extracellular signal‑regulated kinase 1/2 pathways.
    Chen HF; Liu SJ; Chen G
    Mol Med Rep; 2015 Feb; 11(2):1504-8. PubMed ID: 25373458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
    Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
    Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.
    Shen X; Artinyan A; Jackson D; Thomas RM; Lowy AM; Kim J
    Pancreas; 2010 Jan; 39(1):81-7. PubMed ID: 19820417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways.
    Calabro P; Samudio I; Willerson JT; Yeh ET
    Circulation; 2004 Nov; 110(21):3335-40. PubMed ID: 15545519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
    Jang K; Kim M; Seo HS; Shin I
    Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erk1/2 but not PI3K pathway is required for neurotrophin 3-induced oligodendrocyte differentiation of post-natal neural stem cells.
    Hu X; Jin L; Feng L
    J Neurochem; 2004 Sep; 90(6):1339-47. PubMed ID: 15341518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways.
    Chen PN; Hsieh YS; Chiou HL; Chu SC
    Chem Biol Interact; 2005 Oct; 156(2-3):141-50. PubMed ID: 16169542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction pathways for activation of extracellular signal-regulated kinase by arachidonic acid in rat neutrophils.
    Chang LC; Wang JP
    J Leukoc Biol; 2001 Apr; 69(4):659-65. PubMed ID: 11310854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adropin is a novel regulator of endothelial function.
    Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta M; Al-Omran M; Teoh H; Verma S
    Circulation; 2010 Sep; 122(11 Suppl):S185-92. PubMed ID: 20837912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
    Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM
    Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-enhanced endothelial nitric oxide synthase (eNOS) activation in uterine artery endothelial cells shows altered sensitivity to Ca2+, U0126, and wortmannin but not LY294002--evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling.
    Sullivan JA; Grummer MA; Yi FX; Bird IM
    Endocrinology; 2006 May; 147(5):2442-57. PubMed ID: 16455784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
    Albrecht DS; Clubbs EA; Ferruzzi M; Bomser JA
    Chem Biol Interact; 2008 Jan; 171(1):89-95. PubMed ID: 17931610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.